Jefferies Financial Group Inc. Ventyx Biosciences, Inc. Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$29.8 - $40.3 $4.47 Million - $6.05 Million	150,000 Added 121.38%	273,574 $9.5 Million
Q2 2023 Aug 14, 2023	SELL	$28.53 - $39.55 $9.17 Million - $12.7 Million	-321,400 Reduced 72.23%	123,574 $4.05 Million
Q1 2023 May 15, 2023	SELL	$29.51 - $46.65 $739,284 - $1.17 Million	-25,052 Reduced 5.33%	444,974 $14.9 Million
Q4 2022 Sep 21, 2023	BUY	$24.16 - $36.38 $8.37 Million - $12.6 Million	346,452 Added 280.36%	470,026 $15.4 Million
Q4 2022 Feb 14, 2023	BUY	$24.16 - $36.38 $11.4 Million - $17.1 Million	470,026 New	470,026 $15.4 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.